AIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa

Table 1 Demographic and disease characteristics of AIDS-KS patients

Males	112 (59)
Age at time of AIDS-KS diagnosis, years	34(29-41)
Median baseline CD4+ count, cells/mm³	82 (31-174)
Follow-up time, months	278( 38-909)
Disseminated Cutaneous Lesions	72 (38)
IRIS	7 (5)
Site of Kaposi's sarcoma Lesions
Oral	122 (65)
Head	78 (41)
Trunk	68 (36)
Upper Extremity	63 (33)
Lower Extremity	105 (56)
Lymphadenopahthy	42 (22)
Lymphoedema	42 (22)
Gastrointestinal Lesions**	4 (2)
Lung Lesions**	37 (20)
KS Stage
Unstaged	8 (4)
T0	57 (31)
T1	124 (69)
S0	32 (18)
S1	149 (82)

Continous variables are given as medians (interquartile range). Ordinal and discrete variables are given as n(%).
Follow-up time from time of AIDS-KS diagnosis to survival outcome (death, loss-to-follow up, or censor)
IRIS, immune reconstitutioninflammatory syndrome. Denominator n = 137 for patients on cART only
** Suspected cases